CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
Jun. 30, 2025	Jun. 30, 2024
Cash flows from operating activities:
Net income	$ 36,031	$ 28,762
Adjustments to reconcile net income to net cash provided by operating activities:
Provision for credit losses	9,159	6,175
Depreciation and amortization of premises and equipment	3,563	3,454
Loss on disposal of premises and equipment	10	16
Non-cash lease expense	87	0
Cash flows from operating leases	(2,559)	(2,682)
Amortization of mortgage servicing rights	397	370
Net (accretion of discount) amortization of premium on investment securities	(543)	1,099
Share-based compensation	979	1,179
Net gain on sales of residential mortgage loans	(468)	(748)
Proceeds from sales of loans held for sale	37,653	36,620
Originations of loans held for sale	(31,523)	(38,044)
Equity in the (earnings) losses of unconsolidated entities	(33)	31
Distributions from unconsolidated entities	13	0
Net increase in cash surrender value of bank-owned life insurance	(2,757)	(2,756)
Deferred income tax expense	(3,238)	1,165
Net tax expense from share-based compensation	137	128
Net change in other assets and liabilities	7,805	8,177
Net cash provided by operating activities	54,713	42,946
Cash flows from investing activities:
Purchases of investment securities available-for-sale	(50,592)	(62,336)
Proceeds from maturities, prepayments and calls of investment securities available-for-sale	41,623	25,495
Proceeds from maturities, prepayments and calls of investment securities held-to-maturity	19,370	19,545
Net loan payments received	99,776	59,444
Purchases of loan portfolios	(65,463)	(12,384)
Purchases of bank-owned life insurance	(726)	(2,502)
Proceeds from bank-owned life insurance death benefits	2,060	2,248
Net purchases of premises and equipment	(2,888)	(7,932)
Contributions to unconsolidated entities	(650)	(7,787)
Net purchases of FHLB and FRB stock	(17,887)	(132)
Net cash provided by investing activities	24,623	13,659
Cash flows from financing activities:
Net decrease in deposits	(99,022)	(265,137)
Repayments of long-term debt	(25,000)	0
Cash dividends paid on common stock	(14,614)	(14,069)
Repurchases of common stock and other related costs	(4,671)	(945)
Net cash used in financing activities	(143,307)	(280,151)
Net decrease in cash and cash equivalents	(63,971)	(223,546)
Cash and cash equivalents at beginning of period	380,941	522,437
Cash and cash equivalents at end of period	316,970	298,891
Cash paid during the period for:
Interest expense paid	39,127	52,084
Income taxes paid, net	2,222	0
Supplemental disclosure of non-cash information:
Lease liabilities arising from obtaining right-of-use lease assets	1,888	5,029
Amortization of unrealized losses on investment securities transferred to held-to-maturity at fair value	$ 3,325	$ 3,505

The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets, and the amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.

No definition available.